---
title: "CMS ACCESS Expansion: Heart Failure and COPD — Vironix"
description: "CMS is expanding ACCESS in 2027 to heart failure, COPD, substance use disorders, and tobacco cessation. Learn what this means for care between visits."
image: "https://www.vironix.ai/_astro/access-featured_Z1kmdcC.webp"
canonical: "https://www.vironix.ai/news/cms-access-expands-heart-failure-copd"
source: "https://www.vironix.ai/news/cms-access-expands-heart-failure-copd"
---

<!-- Generated from https://www.vironix.ai/news/cms-access-expands-heart-failure-copd. Do not edit this file directly. -->

Nov 19, 2026 · By Vironix Health · [Industry Insights](https://www.vironix.ai/category/industry-insights.md) · 5 min read

# CMS Expands ACCESS to Heart Failure and COPD: What It Means for Care Between Visits

CMS is adding heart failure, COPD, substance use disorders, and tobacco cessation to its ACCESS Model in 2027. Here is what the expansion means for technology-supported care between visits.

![A care coordinator shows an older patient a progress chart on a tablet, with a blood pressure cuff and pulse oximeter on the table](https://www.vironix.ai/_astro/access-featured_ZWLDds.webp)

*The next phase of Medicare's technology-supported care model includes heart failure, COPD, substance use disorders, and tobacco cessation. The opportunity is bigger than collecting more data: it is connecting care at home to measurable progress.*

For people living with chronic conditions, the days between appointments are often when the most important changes happen. Symptoms worsen, routines slip, and small problems can become urgent before the next scheduled visit.

CMS is expanding a model built around that gap. Beginning **April 1, 2027**, its voluntary ACCESS Model will add tracks for heart failure, chronic obstructive pulmonary disease (COPD), substance use disorders, and tobacco cessation. CMS is also extending support for certain chronic musculoskeletal pain conditions beyond the initial 12-month care period.

The announcement widens the range of conditions that can receive ongoing, technology-supported care under ACCESS. It also raises a practical question for practices: **What happens after a change in a patient's health becomes visible?**

## ACCESS pays attention to outcomes, not just activity

ACCESS began in July 2026 with tracks covering common cardio-kidney-metabolic, musculoskeletal, and behavioral-health conditions. It tests a different way to pay Medicare-enrolled care organizations that support people with Original Medicare. Rather than paying only for individual activities, CMS makes recurring payments for managing qualifying conditions and ties full payment to the share of patients who meet measurable health goals. We covered the model’s original announcement in [CMS Announces Tech-Supported Care Model for 2026](https://www.vironix.ai/news/cms-announces-tech-supported-care-model-for-2026.md).

The care can include virtual visits, coaching, remote monitoring, connected devices, or other approaches that suit the patient and condition. ACCESS organizations are expected to coordinate with a patient’s existing clinicians. Referring and primary care clinicians receive electronic care updates on their patients’ progress at initiation, at clinical milestones, and at completion, and they can bill a new co-management payment for documented review of those updates.

Participation is voluntary. People keep their usual Medicare benefits and freedom to see their clinicians. Medicare Advantage members are outside this CMS model, although their plans may offer similar arrangements.

## The new conditions need different kinds of follow-through

Heart failure and COPD show why a single dashboard is not enough. CMS describes the heart-failure track in terms of function, symptom management, and quality of life. Its COPD track aims to help people maintain or improve lung function, ease symptoms, and manage daily activities. Physiologic measurements may help, but those goals also depend on what patients experience and whether the care team responds to meaningful change.

Consider a person with heart failure who reports more difficulty with ordinary activities between visits. The useful question is not simply whether the report or a connected reading reached a platform. It is whether someone reviews it in context, contacts the patient when appropriate, involves the treating clinician, and can later tell whether the care plan helped. That is an illustration of a sound care workflow, **not** a new CMS requirement or a promised result.

The substance-use and tobacco-cessation tracks call for their own approaches. CMS describes support for opioid, alcohol, and other substance use disorders, including care for co-occurring depression and anxiety. Tobacco cessation requires sustained engagement that cannot be reduced to a device reading. Together, the new tracks make the case for matching the support model to the condition instead of treating every form of virtual care as remote patient monitoring.

## What practices should look for

For a practice considering an ACCESS referral, the key questions are different from those used to evaluate a traditional RPM or CCM program. ACCESS is fundamentally an outcome-aligned, technology-supported population health and chronic disease management model. Rather than paying an organization for a defined series of continual monitoring and patient management activities, CMS bases payment on whether its overall patient population achieves specified, condition-specific outcome targets. Technology may collect patient information, deliver education and automated guidance, and support ongoing engagement; ACCESS organizations may also provide clinical services when appropriate. The model therefore places greater emphasis on moving patients toward measurable health goals than on maintaining a prescribed cadence of more intense clinical monitoring or patient contacts.

For practices, the practical questions are:

-   What patient information or responses does the technology collect, and how does it guide the patient toward the track’s defined outcome targets?
-   When does the ACCESS organization determine that a patient’s needs require clinical intervention or escalation?
-   What information is provided to the patient’s regular clinician, and when? CMS requires care updates at initiation, at clinical milestones, and at completion.
-   How does the program measure progress against the condition-specific outcomes that determine ACCESS payment?

At Vironix, we view ACCESS as an important new model for population-level chronic disease management and outcome improvement, but not as a replacement for traditional RPM or CCM. RPM and CCM are designed around ongoing clinical monitoring, patient engagement, documented clinical work, improved individual patient outcomes, and defined Medicare services, and they provide much greater fee-for-service reimbursement to providers. ACCESS takes a different approach: it gives participating organizations flexibility to use technology, automation, patient engagement, and clinical resources as options, while tying much lower payment to measurable outcomes rather than the volume of services delivered.

For a practice evaluating these options, the question should therefore be which model best fits the patient’s needs and the practice’s objectives—not simply whether the patient qualifies for ACCESS. ACCESS can provide an additional population-health pathway for helping patients achieve defined goals, while RPM and CCM provide more intensive, continually managed virtual care when that level of clinical monitoring is appropriate. The strongest virtual-care strategy may ultimately use these models selectively and distinctly, rather than treating ACCESS as a substitute for existing RPM or CCM programs.

## Sources

-   [CMS, “CMS Adds Medicare Options to Help People Manage Substance Use Disorder, Heart Failure, and Other Common Chronic Conditions,” September 15, 2026](https://www.cms.gov/newsroom/press-releases/cms-adds-medicare-options-help-people-manage-substance-use-disorder-heart-failure-other-common)
-   [CMS, ACCESS Model overview](https://www.cms.gov/priorities/innovation/innovation-models/access)
-   [CMS, ACCESS Technical Frequently Asked Questions](https://www.cms.gov/priorities/innovation/access-technical-frequently-asked-questions)

-   [cms](https://www.vironix.ai/tag/cms)
-   [access-model](https://www.vironix.ai/tag/access-model)
-   [heart-failure](https://www.vironix.ai/tag/heart-failure)
-   [copd](https://www.vironix.ai/tag/copd)
-   [virtual-care](https://www.vironix.ai/tag/virtual-care)

Share:

[Back to Insights](https://www.vironix.ai/resources.md)

```json
{
  "@context": "https://schema.org",
  "@type": "Organization",
  "@id": "https://www.vironix.ai/#organization",
  "name": "Vironix Health",
  "alternateName": "Vironix",
  "url": "https://www.vironix.ai",
  "logo": "https://www.vironix.ai/_astro/Vironix_Logo_Primary_300.CFX8xheF.png",
  "description": "Vironix is a digital health platform that enables healthcare providers to provide AI-enabled virtual care services to their patients, including remote patient monitoring, chronic care management, remote therapeutic monitoring, and more.",
  "sameAs": [
    "https://www.linkedin.com/company/vironix",
    "https://www.crunchbase.com/organization/vironix-health"
  ]
}
{
  "@context": "https://schema.org",
  "@type": "WebSite",
  "@id": "https://www.vironix.ai/#website",
  "url": "https://www.vironix.ai",
  "name": "Vironix Health",
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "inLanguage": "en-US"
}
```
